Intranasal dexmedetomidine compositions and methods of use thereof
US10682311B2 · kind B2 · utility
1Cited by
13References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2017 |
| Grant date | Jun 16, 2020 |
| Priority date | — |
| Expiry date | Sep 12, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.